01—Abstract
Summary
Summary of the 10-Q filed November 6, 2015. Cited figures are marked; the original filing is the authoritative source.
Axon Enterprise, Inc. (formerly TASER International, Inc.) reported strong growth in its Axon segment, which includes body cameras and evidence management software, with net sales increasing by over 150%a year-over-year for the third quarter of 2015.
This growth was driven by increased adoption of Axon cameras and Evidence.com subscriptions. Conversely, the TASER Weapons segment saw a slight year-over-year decline in net sales, primarily due to the timing of larger sales transactions and a decrease in sales of the legacy TASER X26 CEW. Overall net sales for the company increased by 13.6%b in the third quarter.
The company's profitability was impacted by increased operating expenses, particularly in sales, general, and administrative (SG&A) and research and development (R&D), largely due to investments in the growing Axon segment. This led to a significant decrease in net income for the quarter compared to the prior year. Despite these investments, the company maintained a healthy cash position and positive cash flow from operations.
02—Key points
Key Highlights
- Axon segment net sales surged by 150.2% year-over-year in Q3 2015, driven by strong adoption of Axon cameras and Evidence.com.
- Overall net sales increased by 13.6% in Q3 2015, reaching $50.4 million, compared to $44.3 million in the prior year.
- TASER Weapons segment sales experienced a slight decline of 1.2% in Q3 2015, largely due to the timing of large transactions and the phasing out of the legacy X26 CEW.
- Operating expenses increased significantly, with SG&A up 43.3% and R&D up 73.7% in Q3 2015, reflecting strategic investments in the Axon segment.
- Net income for Q3 2015 decreased to $1.5 million from $7.6 million in the prior year, impacted by higher operating expenses.
- Bookings for Evidence.com and Axon products and services saw substantial growth, increasing by 141.5% in Q3 2015, indicating strong future revenue potential.
- The company acquired MediaSolv Solutions Corporation for $8.8 million in May 2015, expanding its digital evidence management capabilities.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2015, Axon Enterprise, Inc. kept $0.03.
- Revenue$50.4M100.0%
- Cost of revenue−$19.3M38.3%
- Gross profit$31.1M61.7%
- Operating costs−$24.4M48.4%
- Operating income$6.7M13.3%
- Interest, other & tax−$5.2M10.3%
- Net income$1.5M3.0%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2015filed November 6, 2015Financial Statements
Q3 FY2015 against Q3 FY2014
| Line item | Q3 FY2015Q3 FY2014 | Change |
|---|---|---|
| Revenue | $50.38M$44.35M | +13.6% |
| Cost of Revenue | $19.31M$15.64M | +23.5% |
| Gross Profit | $31.07M$28.71M | +8.2% |
| R&D Expenses | $6.53M$3.76M | +73.7% |
| SG&A Expenses | $17.83M$12.44M | +43.3% |
| Operating Expenses | $24.36M$16.20M | +50.4% |
| Operating Income | $6.71M$12.51M | −46.4% |
| Net Income | $1.52M$7.56M | −79.9% |
| EPS (Basic) | $0.03$0.14 | −78.6% |
| EPS (Diluted) | $0.03$0.14 | −78.6% |
| Shares Outstanding (Basic) | 53.71M52.48M | +2.4% |
| Shares Outstanding (Diluted) | 54.69M53.82M | +1.6% |
05—Questions
Frequently Asked Questions
What is the primary driver of the company's recent revenue growth?
The primary driver of recent revenue growth is the significant expansion of the Axon segment, which includes body cameras, accessories, and Evidence.com software. This segment experienced a 150.2% year-over-year increase in net sales for the third quarter of 2015, fueled by increasing adoption among law enforcement agencies.
Why did net income decrease despite revenue growth?
Net income decreased primarily due to a substantial increase in operating expenses. Sales, General, and Administrative (SG&A) expenses rose by 43.3% and Research & Development (R&D) expenses increased by 73.7% in the third quarter of 2015 compared to the prior year. These increases are attributed to strategic investments in the growing Axon segment, including hiring additional personnel, expanding product offerings, and marketing efforts.
How is the company managing its cash and liquidity?
The company maintained a healthy cash position, with $104.6 million in cash, cash equivalents, and investments as of September 30, 2015. Net cash provided by operating activities was $30.3 million for the first nine months of 2015. The company also has a $10 million revolving line of credit available. The increase in deferred revenue, driven by Evidence.com subscriptions and Axon product sales, also contributes positively to operating cash flow.
What is the company's outlook for the Axon segment?
The outlook for the Axon segment appears strong, as evidenced by the significant increase in net sales and bookings. The company is investing heavily in R&D and SG&A to support this growth, focusing on cloud and mobile technologies, and new product development. The acquisition of MediaSolv also strengthens its position in digital evidence management.
06—Continue